Genastro-1

Manufacturer:

Hetero Labs Limited

Active ingredient:

Anastrazole Tablets IP 1 mg

Adjuvant therapy for early breast cancer with positive hormone receptors in postmenopausal women, including those who have received adjuvant tamoxifen therapy for 2-3 years.